Literature DB >> 1900315

Mechanisms of methicillin resistance in Staphylococcus aureus and methods for laboratory detection.

J H Jorgensen1.   

Abstract

Three distinctly different mechanisms of methicillin resistance have been described in Staphylococcus aureus. The best-documented and probably most important mechanism is production of a unique, low affinity penicillin-binding protein, PBP 2a. Strains possessing PBP 2a are resistant to methicillin, oxacillin, and probably all other currently available beta-lactam antibiotics. Two additional mechanisms of reduced susceptibility to methicillin have been described. Borderline resistance (BORSA) to the semi-synthetic penicillins has been attributed to the hyperproduction of normal staphylococcal beta-lactamase. A third mechanism has recently been advanced that describes an intermediate level of resistance to methicillin due to production of modified, normal PBPs with reduced affinity for beta-lactams (MODSA). Little is known regarding the prevalence or clinical significance of the BORSA and MODSA strains. The most reliable in vitro susceptibility test methods for detecting MRSA (strains possessing PBP 2a) include the microdilution minimum inhibitory concentration (MIC) test (with 2% NaCl supplemented broth), the oxacillin agar screen plate test (incorporating 6 micrograms/ml oxacillin in 4% NaCl supplemented agar), and the National Committee for Clinical Laboratory Standards (NCCLS) disk diffusion test with oxacillin. All three methods use direct inoculum preparation and incubation of tests at 35 degrees C for a full 24 hours.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900315     DOI: 10.1086/646233

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. The Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières.

Authors:  M J Struelens; R Mertens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

2.  Lack of mecA transcription in slime-negative phase variants of methicillin-resistant Staphylococcus epidermidis.

Authors:  M Mempel; H Feucht; W Ziebuhr; M Endres; R Laufs; L Grüter
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

3.  Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.

Authors:  J A Kiehlbauch; G E Hannett; M Salfinger; W Archinal; C Monserrat; C Carlyn
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.

Authors:  Thomas P Lodise; Rienk Pypstra; James B Kahn; Bindu P Murthy; Hui C Kimko; Karen Bush; Gary J Noel; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

5.  Disk Diffusion Testing for Detection of Methicillin-Resistant Staphylococci: Does Moxalactam Improve upon Cefoxitin?

Authors:  Marie Bonjean; Elisabeth Hodille; Oana Dumitrescu; Céline Dupieux; Christina Nkoud Mongo; Camille Allam; Mathilde Beghin; Mickael Paris; Ophelie Borrel; Hubert Chardon; Fréderic Laurent; Jean-Philippe Rasigade; Gerard Lina
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

6.  Rapid detection of methicillin-resistant Staphylococcus aureus by Crystal MRSA ID System.

Authors:  S M Qadri; Y Ueno; H Imambaccus; E Almodovar
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Methicillin-resistant Staphylococcus aureus (MRSA) among dental patients: a problem for infection control in dentistry?

Authors:  Melanie Zimmerli; Andreas F Widmer; Marc Dangel; Andreas Filippi; Reno Frei; Jürg Meyer
Journal:  Clin Oral Investig       Date:  2008-12-23       Impact factor: 3.573

8.  In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey.

Authors:  Hong Bin Kim; Hee-Chang Jang; Hee Jung Nam; Yeong Seon Lee; Bong Su Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

9.  Comprehensive Genomic Investigation of Adaptive Mutations Driving the Low-Level Oxacillin Resistance Phenotype in Staphylococcus aureus.

Authors:  Stefano G Giulieri; Romain Guérillot; Jason C Kwong; Ian R Monk; Ashleigh S Hayes; Diane Daniel; Sarah Baines; Norelle L Sherry; Natasha E Holmes; Peter Ward; Wei Gao; Torsten Seemann; Timothy P Stinear; Benjamin P Howden
Journal:  mBio       Date:  2020-12-08       Impact factor: 7.867

10.  Methicillin-resistant and methicillin-susceptible community-acquired Staphylococcus aureus infection among children.

Authors:  Renata Tavares Gomes; Ticiana Goyanna Lyra; Noraney Nunes Alves; Renilza Menezes Caldas; Maria-Goreth Barberino; Cristiana Maria Nascimento-Carvalho
Journal:  Braz J Infect Dis       Date:  2013-09-19       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.